Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences

19 Aug 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to DNA Repair Mechanisms
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32892059
DOI: 10.1016/j.ctrv.2020.102090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidencesPMID 32892059Read ↗

Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directionsSemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategiesSemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implicationsSemantic proximity Read ↗

The DNA damage response and cancer therapySemantic proximity Read ↗

Targeting DNA damage in SCLCSemantic proximity Read ↗

DNA damage pathways and B-cell lymphomagenesis.Semantic proximity Read ↗

Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?Semantic proximity Read ↗

Targeting DNA Repair Pathways for Cancer Treatment: what’s new?Semantic proximity Read ↗

Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell LymphomaSemantic proximity Read ↗

Targeting DNA repair in breast cancer: A clinical and translational updateSemantic proximity Read ↗

DNA Damage and Its Role in Cancer Therapeutics.Semantic proximity Read ↗

Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.